Larry D. Sutton
22Patents
5h-index
6Co-inventors
58Inventor score
Filing activity: Oct 9, 2008 → Aug 30, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10117755B2 | Multiple spindle adjustable interbody fusion devices and methods of use | Human Necessities | 31 | Active |
| US11090167B2 | Multiple spindle adjustable interbody fusion devices and methods of use | Human Necessities | 24 | Active |
| US9453032B2 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US8883772B2 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US11883428B2 | Enteric aerobization therapy | Emerging Cross-Sectional Technologies | 5 | Active |
| US10000509B2 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9572678B2 | Tissue spacer implants, insertion and adjustment tools, and method of use | Human Necessities | 4 | Active |
| US9862729B2 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US11975023B2 | Methods for inhibiting anaerobic microorganisms | Emerging Cross-Sectional Technologies | 4 | Active |
| US9809605B1 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US11944641B2 | Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy | Emerging Cross-Sectional Technologies | 3 | Active |
| US10239890B2 | Broad spectrum beta-lactamase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US12053488B2 | Compositions for inhibiting anaerobic microorganisms | Emerging Cross-Sectional Technologies | 2 | Active |
| US12036239B2 | Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy | Emerging Cross-Sectional Technologies | 2 | Active |
| US12109244B2 | Enteric aerobization therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12128079B2 | Enteric aerobization therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US9975905B2 | Derivatized 3-styryl-cephalosporins | Chemistry; Metallurgy | 1 | Active |
| US12274726B2 | Enteric aerobization therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US10172720B2 | Tissue spacer implants, insertion and adjustment tools, and method of use | Human Necessities | 0 | Active |
| US11793653B2 | Multiple spindle adjustable interbody fusion devices and methods of use | Human Necessities | 0 | Active |
| US11028103B2 | Derivatized 3-styryl-cephalosporins | Chemistry; Metallurgy | 0 | Active |
| US12239662B2 | Compositions for inhibiting anaerobic microorganisms | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.